These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 32090366)

  • 1. Development of tumour peptide vaccines: From universalization to personalization.
    Ma M; Liu J; Jin S; Wang L
    Scand J Immunol; 2020 Jun; 91(6):e12875. PubMed ID: 32090366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in personalized neoantigen vaccines for cancer immunotherapy.
    Sun C; Xu S
    Biosci Trends; 2020 Nov; 14(5):349-353. PubMed ID: 32908077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The present status and future prospects of peptide-based cancer vaccines.
    Hirayama M; Nishimura Y
    Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification.
    Jou J; Harrington KJ; Zocca MB; Ehrnrooth E; Cohen EEW
    Clin Cancer Res; 2021 Feb; 27(3):689-703. PubMed ID: 33122346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens.
    Pan RY; Chung WH; Chu MT; Chen SJ; Chen HC; Zheng L; Hung SI
    J Immunol Res; 2018; 2018():4325874. PubMed ID: 30662919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoantigen vaccine: an emerging tumor immunotherapy.
    Peng M; Mo Y; Wang Y; Wu P; Zhang Y; Xiong F; Guo C; Wu X; Li Y; Li X; Li G; Xiong W; Zeng Z
    Mol Cancer; 2019 Aug; 18(1):128. PubMed ID: 31443694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer vaccines: Tumor-associated antigens
    Wagner S; Mullins CS; Linnebacher M
    World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
    Aldous AR; Dong JZ
    Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
    Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
    J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old concepts, new tricks: How peptide vaccines are reshaping cancer immunotherapy?
    Liu Q; Wu P; Lei J; Bai P; Zhong P; Yang M; Wei P
    Int J Biol Macromol; 2024 Nov; 279(Pt 4):135541. PubMed ID: 39270889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized cancer vaccination in head and neck cancer.
    Shibata H; Zhou L; Xu N; Egloff AM; Uppaluri R
    Cancer Sci; 2021 Mar; 112(3):978-988. PubMed ID: 33368875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy.
    Supabphol S; Li L; Goedegebuure SP; Gillanders WE
    Expert Opin Investig Drugs; 2021 May; 30(5):529-541. PubMed ID: 33641576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current developments with peptide-based human tumor vaccines.
    Khazaie K; Bonertz A; Beckhove P
    Curr Opin Oncol; 2009 Nov; 21(6):524-30. PubMed ID: 19770763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines.
    Stephens AJ; Burgess-Brown NA; Jiang S
    Front Immunol; 2021; 12():696791. PubMed ID: 34276688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide vaccines in early breast cancer.
    Criscitiello C; Viale G; Curigliano G
    Breast; 2019 Apr; 44():128-134. PubMed ID: 30769238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composite peptide-based vaccines for cancer immunotherapy (Review).
    Yang J; Zhang Q; Li K; Yin H; Zheng JN
    Int J Mol Med; 2015 Jan; 35(1):17-23. PubMed ID: 25395173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses.
    Kumai T; Lee S; Cho HI; Sultan H; Kobayashi H; Harabuchi Y; Celis E
    Cancer Immunol Res; 2017 Jan; 5(1):72-83. PubMed ID: 27941004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic cancer vaccines.
    Saxena M; van der Burg SH; Melief CJM; Bhardwaj N
    Nat Rev Cancer; 2021 Jun; 21(6):360-378. PubMed ID: 33907315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer immunotherapy-targeted glypican-3 or neoantigens.
    Shimizu Y; Suzuki T; Yoshikawa T; Tsuchiya N; Sawada Y; Endo I; Nakatsura T
    Cancer Sci; 2018 Mar; 109(3):531-541. PubMed ID: 29285841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for a personalized peptide vaccine against lung cancer.
    Nakahara Y; Kouro T; Igarashi Y; Kawahara M; Sasada T
    Expert Rev Vaccines; 2019 Jul; 18(7):703-709. PubMed ID: 31225971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.